Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Our Strategic Relationships - Capital Sources

MetaCyte builds relationships with scientists, physicians and entrepreneurs before a company is ever formed. The MetaCyte team becomes part of the management team of the new venture and works closely with the co-founders to drive the new company towards milestones that investors and industry will recognize and value.

Investors in MetaCyte portfolio companies include:

  • Kentucky Seed Capital LLC
  • Triathlon Medical Ventures
  • Kentucky Enterprise Fund
  • Commonwealth Seed Capital, LLC
  • Queen City Angels
  • Bluegrass Angels
  • Louisville Angel Investor Network
  • Enterprise Angels
  • University of Louisville Foundation


  • MetaCyte positions its portfolio companies for later stage financing rounds. We leverage our relationships with venture capital firms nationwide, keeping them advised on the progress of our companies.






    July 16, 2010
    Intrepid Bioinformatics Receives Investment, Meets Milestones

    May 6, 2010
    MetaCyte Business Lab Receives Mention in Nature (PDF)

    March 31, 2010
    MetaCyte Recognized for Innovation

    March 15, 2010
    Teresa Leezer Honored a Second Time for Excellence in Business Management

    February 23, 2010
    Gailar Addresses Leaders as Part of Innovation Panel

    January 2010
    Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

    November 2009
    MetaCyte Advisor Bill Strench Featured in Business First (External Link)

    November 2009
    EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

    August 25, 2009
    Pierce Named Interim Head of UofL Research (External Link)

    July 1, 2009
    AllTranz Named Top Innovator by National Venture Group

    May 8, 2009
    ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

    September 12, 2008
    MetaCyte Team Shows Off New Offices

    June 18, 2008
    Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

    Summer 2006
    A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)